These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

956 related articles for article (PubMed ID: 1832073)

  • 1. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
    Dexter DT; Jenner P; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
    J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
    Riederer P; Sofic E; Rausch WD; Schmidt B; Reynolds GP; Jellinger K; Youdim MB
    J Neurochem; 1989 Feb; 52(2):515-20. PubMed ID: 2911028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
    Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
    Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
    Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN
    J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
    Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA
    Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
    Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.
    Foroutan P; Murray ME; Fujioka S; Schweitzer KJ; Dickson DW; Wszolek ZK; Grant SC
    Radiology; 2013 Jan; 266(1):280-8. PubMed ID: 23151826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.